PhD Aleš Berlec

PhD Aleš Berlec
no.: 24257 source: ARIS

researcher – active in research organisation
  ales.berlecat signijs.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
1,125.69
A''
114.37
A'
577.74
A1/2
684.32
CI10
2,846
CImax
1,302
h10
19
A1
3.93
A3
0.43
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2022, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 60  2,869  2,604  43.4 
Scopus 62  3,212  2,947  47.53 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Petra Štravs   Bologna doctoral studies    55802 
2 PhD Tina Vida Plavec   Bologna doctoral studies  10/1/2018 - 9/30/2021  51651 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2003 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2008 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:100%)  Jožef Stefan Institute  Odsek za biotehnologijo (Slovene)  11/1/2003  Senior research associate  Researcher   
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J3-60060  Extracellular vesicles from recombinant Lactococcus lactis as novel protein delivery vectors for treatment of intestinal inflammation and prevention of colorectal cancer   1/1/2025 - 12/31/2027  PhD Tina Vida Plavec   1,193 
2. J4-60079  Targeting extracellular polymeric substances to prevent bacterial persistence in biofilms   1/1/2025 - 12/31/2027  PhD Jerica Sabotič   2,710 
3. BI-FR/24-25-PROTEUS-001  Engineering and characterization of Lactococcus lactis expressing cellulases   1/1/2025 - 12/31/2025  PhD Aleš Berlec   256 
4. BI-FR/24-25-PROTEUS-001  Engineering and characterization of Lactococcus lactis with expressed cellulases   1/1/2024 - 12/31/2025  PhD Aleš Berlec   256 
5. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   12/1/2021 - 11/30/2025  PhD Stane Pajk   2,823 
6. J7-4418  Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections   10/1/2022 - 9/30/2025  PhD Špela Zupančič   5,917 
7. J7-4420  Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles   10/1/2022 - 9/30/2025  PhD Aleš Berlec   4,253 
8. J4-3088  Intra-biofilm dynamics of Campylobacter with other bacteria: effects on biofilm formation and composition with a view to the design of innovative control strategies   10/1/2021 - 9/30/2024  PhD Anja Klančnik   4,486 
9. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile   10/1/2021 - 9/30/2024  PhD Borut Štrukelj   3,365 
10. N3-0184  Small protein blockers of IL-23/IL-17 axis as intestinal inflammation inhibitors secreted by probiotic bacteria   3/1/2021 - 2/29/2024  PhD Aleš Berlec   1,426 
11. J4-1776  Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F   7/1/2019 - 6/30/2022  PhD Janko Kos   3,284 
12. J4-1771  NEW ANTIMICROBIAL STRATEGIES IN PREVENTION OF BIOFILM FORMATION BY USING LECTINS THAT INHIBIT BACTERIAL ADHESION   7/1/2019 - 6/30/2022  PhD Jerica Sabotič   2,386 
13. J4-9299  Targeting Campylobacter adhesion in the fight against antimicrobial resistance   7/1/2018 - 6/30/2022  PhD Anja Klančnik   3,969 
14. J4-9327  Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria   7/1/2018 - 6/30/2021  PhD Aleš Berlec   2,624 
15. J1-5450  Proteinsko načrtovanje rekombinantnih probiotičnih mlečnokislinskih bakterij za zdravljenje sindromov vnetega črevesa (Slovene)   8/1/2013 - 7/31/2016  PhD Borut Štrukelj   2,579 
16. J4-4123  Inhibitorji cisteinskih karboksipeptidaz kot regulatorji avtoimunskih in nevrodegenerativnih procesov (Slovene)   7/1/2011 - 6/30/2014  PhD Janko Kos   6,858 
17. L4-1046  Nove zdravilne učinkovine biotehnološkega izvora z uporabo bakteriofagnega prikaza (Slovene)   2/1/2008 - 1/31/2011  PhD Borut Štrukelj   4,291 
18. J4-9425  Lektini kot modulatorji protitumorskega imunskega odziva (Slovene)   1/1/2007 - 12/31/2009  PhD Janko Kos   2,344 
19. J4-9476  Vrednotenje genotipov fižola (Phaseolus vulgaris L.) s pomočjo kandidatnih genov za odpornost proti suši (Slovene)   1/1/2007 - 12/31/2009  PhD Vladimir Meglič   4,065 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P4-0127  Pharmaceutical biotechnology: Science for health   1/1/2019 - 12/31/2027 PhD Janko Kos   5,511 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   1/1/2015 - 12/31/2018 PhD Janko Kos   5,367 
3. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2009 - 12/31/2014 PhD Janko Kos   5,883 
4. P4-0127  Pharmaceutical biotechnology: Knowledge for Health   1/1/2004 - 12/31/2008 PhD Janko Kos   5,665 
Confirmation required
Views history
Favourite